Residents' corner September 2011. Residents' editorial choice

Eur J Dermatol. 2011 Sep-Oct;21(5):826-7. doi: 10.1684/ejd.2011.1502.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Carcinoma, Basal Cell / epidemiology*
  • Dacarbazine / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Immunologic Factors / therapeutic use*
  • Ipilimumab
  • Melanoma / drug therapy*
  • Psoriasis / drug therapy*
  • Recombinant Fusion Proteins / therapeutic use*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / epidemiology*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents, Alkylating
  • Immunologic Factors
  • Ipilimumab
  • LFA3-IgG1 fusion protein, human
  • Recombinant Fusion Proteins
  • Dacarbazine